Lasa Supergenerics Limited — Important, 11-02-2025: General Updates

An Extraordinary General Meeting (EGM) of Lasa Supergenerics Limited is scheduled for February 22, 2025, to address special business matters. A corrigendum has been issued regarding the use of funds from a proposed preferential issue, specifying that Rs. 350 Cr will be allocated for the repayment of unsecured debt to Shree Vasudev Exim and another Rs. 350 Cr for working capital needs. This initiative aims to streamline liabilities and enhance financial health. The pricing for the warrants in the preferential issue has been set at Rs. 28, aligning with revised compliance measures and ensuring that it exceeds the minimum price of Rs. 27.78 determined under relevant regulations. Shareholders are encouraged to submit any queries regarding the accounts or matters for discussion at least a week before the meeting.